Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease filed in South Korea

STOCKHOLM, June 8, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has submitted a marketing authorization application for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] with confirmed amyloid pathology in the brain, to the Ministry of … Read more

Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease filed in South Korea

STOCKHOLM, June 8, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has submitted a marketing authorization application for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] with confirmed amyloid pathology in the brain, to the Ministry of … Read more

Major Players Include Elliot Scientific, Shanghai Laser & Optics Century, GenSight Biologics and Danaher

DUBLIN, June 7, 2023 /PRNewswire/ — The “Optogenetics Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global optogenetics market is expected to grow from $28.15 billion in 2022 to $32.26 billion in 2023 … Read more

Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth

DUBLIN, June 7, 2023 /PRNewswire/ — The “Peptide Therapeutics Market – Growth, Trends, COVID-19 Impact and Forecasts (2023-2028)” report has been added to  ResearchAndMarkets.com’s offering. The peptide therapeutics market is expected to register a CAGR of 9.66% over the forecast period. Companies Mentioned Eli Lilly and Company Amgen Inc. Pfizer Inc. Bristol-Myers Squibb Company Ever … Read more

Increasing Prevalence of Neonatal Pulmonary Hypertension and Acute Respiratory Distress Syndrome Drives Growth

DUBLIN, June 7, 2023 /PRNewswire/ — The “Nitric Oxide Therapy Systems Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to  ResearchAndMarkets.com’s offering. The global nitric oxide therapy system market is expected to grow at a CAGR of around 4.1% during 2023-2030. Companies Mentioned Bellerophon Therapeutics BOC Healthcare Dan Hammer Health … Read more

Auna S.A.A. Announces Expiration and Receipt of Requisite Consents with Respect to Consent Solicitation for Senior Notes due 2025

MEXICO CITY and LIMA, Peru, June 7, 2023 /PRNewswire/ — Auna S.A.A. (“Auna” or the “Company“) announced today the expiration of its previously announced solicitation (the “Consent Solicitation“) of consents (the “Consents“) and receipt of the requisite Consents from holders (the “Holders“) of Auna’s outstanding 6.500% Senior Notes due 2025 (the “Notes“) to effect a … Read more